Inhibition of β2 integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides

Journal of Cell Biology

Volumn 153, Issue 5, 2001, Pages 905-915

  Koivunen, Erkki ^a   Ranta, Tanja Maria ^a   Annila, Arto ^a   Taube, Seija ^a   Uppala, Asko ^a   Jokinen, Marjukka ^a   Van Willigen, Gijsbert ^a   Ihanus, Eveliina ^a   Gahmberg, Carl G ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cell adhesion; Extracellular matrix; Leukocyte; Peptides; Phage display

Indexed keywords

BETA2 INTEGRIN; CYSTEINYLPROLYLCYSTEINYLPHENYLALANYLLEUCYLLEUCYLGLYCYLLEUCYLLEUCINE; INTERCELLULAR ADHESION MOLECULE 1; MATRIX PROTEIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE; PHAGE DISPLAY; PRIORITY JOURNAL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD18; CATIONS, DIVALENT; CELL ADHESION; CELL MOVEMENT; DISULFIDES; EDETIC ACID; GLUTARAL; GLYCINE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUCINE; LEUKOCYTES; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED; VON WILLEBRAND FACTOR;

EID: 0035947769     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.153.5.905     Document Type: Article

References (53)

1. Solution structures and integrin binding activities of an RGD peptide with two isomers
2. The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins
3. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand
4. A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1
5. Lymphocyte functionassociated antigen-1 binding residues in intercellular adhesion molecule-2 (ICAM-2) and the integrin binding surface in the ICAM subfamily
6. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment
7. Type A modules: Interacting domains found in several non-fibrillar collagens and in other extracellular matrix proteins
8. Organization of the human pro-alpha 2(I) collagen gene
9. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes
10. Peptides derived from the complementary-determining regions of anti-Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1
11. Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1
12. Leukocyte adhesion. Structure and function of human leukocyte integrins and their cellular ligands
13. Torsion angle dynamics for NMR structure calculation with the new program DYANA
14. Physical separation of ICAM-I binding cells
15. VLA proteins in the integrin family: Structures, functions, and their role on leukocytes
16. A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule-1 (ICAM-1)
17. Integrins: Versatility, modulation, and signalling in cell adhesion
18. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain
19. 2 integrins for interactions of intercellular adhesion molecule-1 (ICAM-1) and C3bi
20. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1
21. A small molecule antagonist of LFA-1-mediated cell adhesion
22. 1 integrin from a phage display library
23. Phage libraries displaying cyclic peptides with different ring sizes: Ligand specificities of the RGD-directed integrins
24. Tumor targeting with a selective gelatinase inhibitor
25. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine
26. ICAM-2 and a peptide from its binding domain are efficient activators of leukocyte adhesion and integrin affinity
27. 6 integrin
28. Resistance of ICAM-1-deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells
29. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway
30. Von Willebrand factor without the A2 domain is resistant to proteolysis
31. Crystal structure of the A domain from the α-subunit of integrin CR3 (CD11b/CD18)
32. Complete primary structure of the human type IV collagen alpha 4(IV) chain. Comparison with structure and expression of the other alpha (IV) chains
33. A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion
34. A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18
35. Molecular cloning of cDNA for human von Willebrand factor: Authentication by a new method
36. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
37. 2+
38. Immunological mapping of the human leukocyte adhesion glycoprotein gp90 (CD18) by monoclonal antibodies
39. The secondary structure of the von Willebrand factor type A-domain in factor B of human complement by Fourier transform infrared spectroscopy: Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions
40. The cell attachment activity of fibronectin can be duplicated by small fragments of the molecule
41. 2) integrin
42. Inhibition of Molt-4-endothelial adherence by synthetic peptides from the sequence of ICAM-1
43. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor
44. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
45. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM
46. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
47. The I domain of integrin LFA-1 interacts with ICAM-1 domain 1 at residue Glu-34 but not Gln-73
48. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous ICAM-1
49. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus
50. The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 integrin
51. 2 integrin CR3 (CD11b/CD18)
52. Treatment with ockadaic acid reveals strong threonine phosphorylation of CD18 after activation of CD11/CD18 leukocyte integrins with phorbol esters or CD3 antibodies
53. 1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium